Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retina | 5 | 2023 | 421 | 1.790 |
Why?
|
Caveolin 1 | 4 | 2023 | 43 | 1.660 |
Why?
|
Glucose Transporter Type 4 | 3 | 2017 | 62 | 1.180 |
Why?
|
Inflammation | 2 | 2020 | 601 | 1.000 |
Why?
|
Lipopolysaccharides | 2 | 2021 | 152 | 0.840 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2021 | 2 | 0.770 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 74 | 0.740 |
Why?
|
Retinitis | 1 | 2020 | 8 | 0.720 |
Why?
|
Neurons | 1 | 2021 | 275 | 0.660 |
Why?
|
Glucose | 2 | 2017 | 191 | 0.620 |
Why?
|
Transcription Factors | 1 | 2021 | 511 | 0.580 |
Why?
|
Physical Conditioning, Animal | 1 | 2016 | 34 | 0.530 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 627 | 0.530 |
Why?
|
Amino Acids | 1 | 2016 | 80 | 0.520 |
Why?
|
Mitochondria | 1 | 2016 | 333 | 0.440 |
Why?
|
Mice | 7 | 2021 | 4406 | 0.400 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 578 | 0.390 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 1475 | 0.380 |
Why?
|
Mice, Knockout | 4 | 2021 | 782 | 0.370 |
Why?
|
Obesity | 1 | 2016 | 650 | 0.360 |
Why?
|
Electroretinography | 2 | 2021 | 173 | 0.350 |
Why?
|
Blotting, Western | 3 | 2020 | 503 | 0.320 |
Why?
|
Animals | 8 | 2021 | 9962 | 0.310 |
Why?
|
Hot Temperature | 1 | 2023 | 84 | 0.200 |
Why?
|
Receptors, CCR2 | 1 | 2021 | 4 | 0.190 |
Why?
|
Disease Models, Animal | 3 | 2021 | 1394 | 0.190 |
Why?
|
Immunity | 1 | 2021 | 26 | 0.190 |
Why?
|
Uveitis | 1 | 2021 | 23 | 0.190 |
Why?
|
Endothelial Cells | 2 | 2020 | 324 | 0.180 |
Why?
|
Visual Acuity | 1 | 2021 | 106 | 0.180 |
Why?
|
Nystagmus, Optokinetic | 1 | 2020 | 4 | 0.180 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2020 | 7 | 0.180 |
Why?
|
Transcriptional Regulator ERG | 1 | 2020 | 10 | 0.180 |
Why?
|
Intravitreal Injections | 1 | 2020 | 33 | 0.180 |
Why?
|
Oncogene Proteins | 1 | 2020 | 21 | 0.180 |
Why?
|
Eye | 1 | 2020 | 35 | 0.180 |
Why?
|
Aqueous Humor | 1 | 2020 | 24 | 0.180 |
Why?
|
Drug Synergism | 1 | 2020 | 100 | 0.180 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 110 | 0.180 |
Why?
|
Intraocular Pressure | 1 | 2020 | 61 | 0.170 |
Why?
|
Glaucoma | 1 | 2020 | 52 | 0.170 |
Why?
|
Salmonella typhimurium | 1 | 2020 | 68 | 0.170 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 70 | 0.170 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 163 | 0.170 |
Why?
|
Flow Cytometry | 1 | 2020 | 282 | 0.170 |
Why?
|
Mass Spectrometry | 1 | 2020 | 186 | 0.170 |
Why?
|
Immunohistochemistry | 1 | 2020 | 453 | 0.160 |
Why?
|
Adherens Junctions | 1 | 2019 | 8 | 0.160 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 27 | 0.160 |
Why?
|
Proteomics | 1 | 2020 | 177 | 0.160 |
Why?
|
Macrophages | 1 | 2021 | 274 | 0.160 |
Why?
|
DNA | 1 | 2020 | 365 | 0.160 |
Why?
|
Cytokines | 1 | 2020 | 439 | 0.150 |
Why?
|
Cell Membrane | 1 | 2019 | 235 | 0.150 |
Why?
|
Adipocytes, White | 1 | 2017 | 10 | 0.150 |
Why?
|
Adipogenesis | 1 | 2017 | 17 | 0.150 |
Why?
|
NADP | 1 | 2017 | 38 | 0.140 |
Why?
|
NAD | 1 | 2017 | 81 | 0.140 |
Why?
|
Retinal Degeneration | 1 | 2019 | 141 | 0.140 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2016 | 10 | 0.140 |
Why?
|
Glycogen | 1 | 2016 | 20 | 0.140 |
Why?
|
Naphthyridines | 1 | 2016 | 4 | 0.140 |
Why?
|
Mice, Obese | 1 | 2016 | 20 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2016 | 20 | 0.140 |
Why?
|
Biological Transport | 1 | 2016 | 111 | 0.130 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 57 | 0.130 |
Why?
|
Triglycerides | 1 | 2016 | 117 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 68 | 0.130 |
Why?
|
Lipid Metabolism | 1 | 2016 | 118 | 0.130 |
Why?
|
Sirolimus | 1 | 2016 | 68 | 0.130 |
Why?
|
Adiposity | 1 | 2016 | 87 | 0.130 |
Why?
|
Diet, High-Fat | 1 | 2016 | 130 | 0.130 |
Why?
|
Mice, Transgenic | 1 | 2016 | 486 | 0.120 |
Why?
|
Blood Glucose | 1 | 2016 | 300 | 0.120 |
Why?
|
Insulin Resistance | 1 | 2016 | 165 | 0.120 |
Why?
|
Liver | 1 | 2016 | 415 | 0.110 |
Why?
|
Aging | 1 | 2019 | 945 | 0.100 |
Why?
|
Male | 2 | 2016 | 12874 | 0.090 |
Why?
|
Humans | 4 | 2020 | 26846 | 0.090 |
Why?
|
Neuroglia | 1 | 2023 | 30 | 0.050 |
Why?
|
Molecular Weight | 1 | 2023 | 118 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2020 | 18 | 0.050 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2020 | 50 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2020 | 163 | 0.040 |
Why?
|
Retinal Vessels | 1 | 2020 | 71 | 0.040 |
Why?
|
Blood Vessels | 1 | 2020 | 58 | 0.040 |
Why?
|
Indoles | 1 | 2020 | 98 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 104 | 0.040 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2019 | 13 | 0.040 |
Why?
|
Vacuoles | 1 | 2019 | 10 | 0.040 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2019 | 18 | 0.040 |
Why?
|
Endothelium | 1 | 2019 | 28 | 0.040 |
Why?
|
Oxygen | 1 | 2020 | 218 | 0.040 |
Why?
|
Sphingosine | 1 | 2019 | 22 | 0.040 |
Why?
|
Cadherins | 1 | 2019 | 24 | 0.040 |
Why?
|
Sphingolipids | 1 | 2019 | 20 | 0.040 |
Why?
|
Ependymoglial Cells | 1 | 2019 | 29 | 0.040 |
Why?
|
Lysophospholipids | 1 | 2019 | 48 | 0.040 |
Why?
|
Retinal Pigment Epithelium | 1 | 2019 | 90 | 0.040 |
Why?
|
Liver X Receptors | 1 | 2017 | 20 | 0.040 |
Why?
|
Adipose Tissue, White | 1 | 2017 | 16 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2017 | 27 | 0.040 |
Why?
|
Adiponectin | 1 | 2017 | 29 | 0.040 |
Why?
|
Lipogenesis | 1 | 2017 | 29 | 0.040 |
Why?
|
Hypoglycemia | 1 | 2017 | 33 | 0.040 |
Why?
|
Stromal Cells | 1 | 2017 | 60 | 0.040 |
Why?
|
Apoptosis | 1 | 2020 | 739 | 0.030 |
Why?
|
Phenotype | 1 | 2019 | 667 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2017 | 77 | 0.030 |
Why?
|
Up-Regulation | 1 | 2017 | 240 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 333 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2017 | 970 | 0.030 |
Why?
|
Signal Transduction | 1 | 2020 | 1344 | 0.030 |
Why?
|
Biomarkers | 1 | 2017 | 733 | 0.030 |
Why?
|